[1] Zhu B, You SL, Wan ZH,et al.Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure. World J Gastroenterol, 2014,20:7473-7479.
[2] Lee WM, Squires RH, Nyberg SL, et al.Acute liver failure: Summary of a workshop. Hepatology,2008,47: 1401-1415.
[3] You S, Rong Y, Zhu B,et al. Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey.Hepa Inter 2013: 7:714-720.
[4] 高晓琴,赵永勋,任茜,等. 药物诱导的自身免疫性肝炎的研究进展. 临床肝胆病杂志,2017,33:2222-2225.
[5] van Gemeren MA, van Wijngaarden P, Doukas M, et al. Vaccine-related autoimmune hepatitis: the same disease as idiopathic autoimmunehepatitis? Two clinical reports and review.Scand J Gastroenterol,2017,52: 18-22.
[6] Rigopoulou EI, Smyk DS, Matthews CE, et al. Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol,2012,2012: 987471.
[7] Pischke S, Gisa A, Suneetha PV, et al. Increased HEV seroprevalence in patients with autoimmune hepatitis. PLoS One,2014,9:e85330.
[8] Tian QH,Zhu SX.Research progress of Epstein-Barr virus-related disease in infants. Int J Virol,2017,24: 69-72.
[9] 张慧, 李双杰, 袁远宏, 等.EB 病毒感染肝脏损伤与外周血淋巴细胞亚群相关性.临床儿科杂志, 2013, 31:233-235. |
